Bone mineral density and the risk of peripheral arterial disease: The Rotterdam Study

Calcified Tissue International

Volumn 70, Issue 6, 2002, Pages 443-449

  Van der Klift, M ^a   Pols, Hubert A P ^a   Hak, A E ^a   Witteman, J C M ^a   Hofman, A ^a   De Laet, C E D H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bone mineral density; Cohort; Peripheral arterial disease; Population based study; Women

Indexed keywords

ANTIDIABETIC AGENT; DIURETIC AGENT; ESTROGEN;

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BONE DENSITY; BONE MINERAL; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN DEFICIENCY; FEMALE; FEMUR NECK; HORMONE SUBSTITUTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; CROSS-SECTIONAL STUDY; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; POSTMENOPAUSE OSTEOPOROSIS; RADIOGRAPHY; RISK;

AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; OSTEOPOROSIS, POSTMENOPAUSAL; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 0036593997     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-2076-9     Document Type: Article

References (40)

1. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV (1998) Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62:209-213
2. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC (2000) Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 20:1926-1931
3. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B (1994) Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13:611-614
4. Vogt MT, Cauley JA, Kuller LH, Nevitt MC (1997) Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res 12:283-289
5. Vogt MT, San Valentin R, Forrest KY, Nevitt MC, Cauley JA (1997) Bone mineral density and aortic calcification: the Study of Osteoporotic Fractures. J Am Geriatr Soc 45:140-145
6. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A (1997) Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28:1730-1732
7. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, Dobs A, Evans GW, Heiss G (1997) Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 131:115-125
8. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK (1993) Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88:837-845
9. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7:403-422
10. Stegall HF, Kardon MB, Kemmerer WT (1968) Indirect measurement of arterial blood pressure by Doppler ultrasonic sphygmomanometry. J Appl Physiol 25:793-798
11. Prineas RJ, Harland WR, Janzon L, Kannel W (1982) Recommendations for use of non-invasive methods to detect atherosclerotic peripheral arterial disease in population studies. American Heart Association Council on Epidemiology. Circulation 65:1561A-1566A
12. Schroll M, Munck O (1981) Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 34:261-269
13. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ (1991) Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384-392
14. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE (1998) Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18:185-192
15. Burger H, van Daele PL, Algra D, van den Ouweland FA, Grobbee DE, Hofman A, van Kuijk C, Schutte HE, Birkenhager JC, Pols HA (1994) The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. Bone Miner 25:1-13
16. Rose G, Blackburn H, Gillum R, Prineas R (1982) Cardiovascular survey methods. Geneva: World Health Organization
17. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346-1353
18. Ross PD (1996) Osteoporosis. Frequency, consequences, and risk factors. Arch Intern Med 156:1399-1411
19. TASC Working Group (2000) Chapter 2A: epidemiology, natural history, risk factors. J Vasc Surgery 31:S5-S28
20. Christiansen C, Lindsay R (1990) Estrogens, bone loss and preservation. Osteoporos Int 1:7-13
21. Falch JA, Sandvik L (1990) Perimenopausal appendicular bone loss: a 10-year prospective study. Bone 11:425-428
22. Riggs BL, Khosla S, Melton LJ 3rd (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men [see comments]. J Bone Miner Res 13:763-773
23. Kalin MF, Zumoff B (1990) Sex hormones and coronary disease: a review of the clinical studies. Steroids 55:330-352
24. The writing group for the PEPI trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 273:199-208
25. Barrett-Connor E (1997) Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95:252-264
26. Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
27. Khosla S, Atkinson EJ, Melton LJ 3rd, Riggs BL (1997) Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 82:1522-1527
28. McKane WR, Khosla S, Risteli J, Robins SP, Muhs JM, Riggs BL (1997) Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proc Assoc Am Physicians 109:174-180
29. Khaw KT, Sneyd MJ, Compston J (1992) Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle-aged women. BMJ 305:273-277
30. Reginster JY, Deroisy R, Pirenne H, Frederick I, Dewe W, Albert A, Collette J, Zheng SX, Gosset C (1999) High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community dwelling: a plausible role of increased parathyroid hormone secretion. Osteoporos Int 9:121-128
31. Barenbrock M, Hausberg M, Kosch M, Kisters K, Hoeks AP, Rahn KH (1998) Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients. Kidney Int 54:210-215
32. Rostand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383-392
33. Hak AE, Polderman KH, Westendorp IC, Jakobs C, Hofman A, Witteman JC, Stehouwer CD (2000) Increased plasma homocysteine after menopause [In Process Citation]. Atherosclerosis 149:163-168
34. Zhu X, Bonet B, Knopp RH (2000) Estradiol 17beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees. Atherosclerosis 148:31-41
35. Christen WG, Ajani UA, Glynn RJ, Hennekens CH (2000) Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 160:422-434
36. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66: 190-194
37. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680-687
38. Barker DJ (1999) Early growth and cardiovascular disease. Arch Dis Child 80:305-307
39. Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C (2001) Intrauterine programming of adult body composition. J Clin Endocrinol Metab 86:267-272
40. Burger H, van Daele PL, Odding E, Valkenburg HA, Hofman A, Grobbee DE, Schutte HE, Birkenhager JC, Pols HA (1996) Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study. Arthritis Rheum 39:81-86